KYKOF (Kyowa Kirin Co) Total Long-Term Assets: $3,941 Mil (As of Dec. 2025)


KYKOF Kyowa Kirin Co Ltd KYKOF
82 GF Score
Price $14.43
GF Value $17.76
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co Total Long-Term Assets?

Kyowa Kirin Co KYKOF 82 Total Long-Term Assets is $3,941 Mil as of Dec. 2025. GuruFocus rates KYKOF with a GF Score™ of 82/100 and a GF Value™ of $17.76 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Kyowa Kirin Co's Total Long-Term Assets for the quarter that ended in Dec. 2025 was $3,941 Mil.

Kyowa Kirin Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Kyowa Kirin Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co Total Long-Term Assets Chart

Kyowa Kirin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,545.91 2,947.73 2,881.05 3,662.45 3,941.33

Kyowa Kirin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,817.62 3,984.23 3,967.53 3,941.33 3,827.03
KYKOF
82GF Score
Kyowa Kirin Co Ltd KYKOF
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $3,941 Mil mean?
Kyowa Kirin Co (KYKOF) has a Total Long-Term Assets of $3,941 Mil as of Dec. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Total Long-Term Assets too high?
Kyowa Kirin Co's current Total Long-Term Assets is $3,941 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Total Long-Term Assets compare to ZTS and UTHR?
Kyowa Kirin Co's Total Long-Term Assets of $3,941 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Drug Manufacturers company?
A good Total Long-Term Assets depends on the Drug Manufacturers industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Total Long-Term Assets is $3,941 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (KYKOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $17.76, compared to a current price of $14.43 — trading 18.8% below its estimated fair value. The current Total Long-Term Assets is $3,941 Mil. Kyowa Kirin Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Kyowa Kirin Co (KYKOF), the current Total Long-Term Assets is $3,941 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (KYKOF) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of $14.43 is trading 18.8% below its estimated GF Value™ of $17.76. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for KYKOF:

  • Total Long-Term Assets: $3,941 Mil
  • GF Value™: $17.76 vs. price of $14.43 (18.8% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the KYKOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
82GF Score

Get the complete analysis for KYKOF

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.43
Price
$17.76
GF Value